Lapatinib-d7 ditosylate structure
|
Common Name | Lapatinib-d7 ditosylate | ||
---|---|---|---|---|
CAS Number | 1009307-24-7 | Molecular Weight | 753.25900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C36H34ClFN4O7S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Lapatinib-d7 ditosylateLapatinib-d7 (GW572016-d7) ditosylate is the deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1][2]. |
Name | N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[1,1,2,2-tetradeuterio-2-(trideuteriomethylsulfonyl)ethyl]amino]methyl]furan-2-yl]quinazolin-4-amine,4-methylbenzenesulfonic acid |
---|---|
Synonym | More Synonyms |
Description | Lapatinib-d7 (GW572016-d7) ditosylate is the deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C36H34ClFN4O7S2 |
---|---|
Molecular Weight | 753.25900 |
Exact Mass | 752.15400 |
PSA | 177.48000 |
LogP | 10.00630 |
N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl-d7]amino]methyl]-2-furanyl]-4-quinazolinamine Bis(4-methylbenzenesulfonate) Ditosylate |
Tykerb-d7 Ditosylate |
Lapatinib-d7 Ditosylate |